111 related articles for article (PubMed ID: 2170143)
1. Evaluation of primary lung carcinoma using technetium 99m-hexamethylpropylene amine oxime: preliminary clinical experience.
Oshima M; Itoh K; Okae S; Tadokoro M; Kodama Y; Sakuma S
Eur J Nucl Med; 1990; 16(12):859-64. PubMed ID: 2170143
[TBL] [Abstract][Full Text] [Related]
2. Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single-photon emission computerized tomography.
Carvalho PA; Schwartz RB; Alexander E; Garada BM; Zimmerman RE; Loeffler JS; Holman BL
J Neurosurg; 1992 Oct; 77(4):565-70. PubMed ID: 1527616
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of technetium 99m cyclobutylpropylene amine oxime as a potential brain perfusion imaging agent for SPET.
Bacciottini L; Lunghi F; Pupi A; Bonino C; Formiconi AR; De Cristofaro MT; Petti AR; Meldolesi U
Eur J Nucl Med; 1990; 17(5):242-7. PubMed ID: 2083559
[TBL] [Abstract][Full Text] [Related]
4. Imaging tumor hypoxia and tumor perfusion.
Groshar D; McEwan AJ; Parliament MB; Urtasun RC; Golberg LE; Hoskinson M; Mercer JR; Mannan RH; Wiebe LI; Chapman JD
J Nucl Med; 1993 Jun; 34(6):885-8. PubMed ID: 8389842
[TBL] [Abstract][Full Text] [Related]
5. Increment of brain temporal perfusion during auditory stimulation. Preliminary study with technetium-99m HMPAO SPET.
Le Scao Y; Baulieu JL; Robier A; Pourcelot L; Beutter P
Eur J Nucl Med; 1991; 18(12):981-3. PubMed ID: 1778211
[TBL] [Abstract][Full Text] [Related]
6. 99Tcm-labelled meso-HMPAO and glutathione content of human lung tumours.
Rowell NP; McCready VR; Cronin B; Pepper J; Higley B; Burke JF; Tyrrell DA
Nucl Med Commun; 1989 Jul; 10(7):503-8. PubMed ID: 2552364
[TBL] [Abstract][Full Text] [Related]
7. Adrenoleukodystrophy: cortical hypoperfusion demonstrated with 99mTc-HMPAO SPECT.
al Suhaili AR; Hertecant J; Sztriha L
J Child Neurol; 1994 Jul; 9(3):284-6. PubMed ID: 7930407
[TBL] [Abstract][Full Text] [Related]
8. Bilateral subdural hematomas diagnosed with technetium-99m-HMPAO brain SPECT.
Coupland D; Lentle B
J Nucl Med; 1991 Oct; 32(10):1915-7. PubMed ID: 1919732
[TBL] [Abstract][Full Text] [Related]
9. A multi-institutional study of interobserver agreement in the evaluation of dementia with rCBF/SPET technetium-99m exametazime (HMPAO).
Hellman RS; Tikofsky RS; Van Heertum R; Coade G; Carretta R; Hoffmann RG
Eur J Nucl Med; 1994 Apr; 21(4):306-13. PubMed ID: 8005154
[TBL] [Abstract][Full Text] [Related]
10. Measurement of the secretion of technetium-99m hexamethylpropylene amine oxime into breast milk.
Marshall DS; Newberry NR; Ryan PJ
Eur J Nucl Med; 1996 Dec; 23(12):1634-5. PubMed ID: 8929318
[TBL] [Abstract][Full Text] [Related]
11. [Clinical assessment of 99mTc-HMPAO scintigraphy in thoracic tumors].
Suga K; Kawamura M; Nishigauchi K; Yoneshiro S; Fujita T; Ohno Y; Matsumoto T; Nakanishi T; Utsumi H; Yamada N
Kaku Igaku; 1992 Sep; 29(9):1143-9. PubMed ID: 1453565
[TBL] [Abstract][Full Text] [Related]
12. Semi-automatic quantification of regional cerebral perfusion in primary degenerative dementia using 99m technetium-hexamethylpropylene amine oxime and single photon emission tomography.
Goulding P; Burjan A; Smith R; Lawson R; Snowden J; Northen B; Neary D; Testa H
Eur J Nucl Med; 1990; 17(1-2):77-82. PubMed ID: 2083546
[TBL] [Abstract][Full Text] [Related]
13. Tc-99m MDP uptake in cerebral infarction: comparison with Tc-99m DTPA brain scan and Tc-99m HMPAO brain SPECT.
Peng NJ; Tsay DG; Chen CY; Liu RS; Yeh SH
Zhonghua Yi Xue Za Zhi (Taipei); 1995 Oct; 56(4):283-7. PubMed ID: 8548673
[TBL] [Abstract][Full Text] [Related]
14. Tc-99m HM-PAO pulmonary imaging of large cell carcinoma in the lung of a smoker showing a rounded photon deficient area.
Shih WJ; Dillon ML
Radiat Med; 1993; 11(2):56-9. PubMed ID: 8391153
[TBL] [Abstract][Full Text] [Related]
15. Regional differences between 99mTc-ECD and 99mTc-HMPAO SPET in perfusion changes with age and gender in healthy adults.
Inoue K; Nakagawa M; Goto R; Kinomura S; Sato T; Sato K; Fukuda H
Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1489-97. PubMed ID: 14579088
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of brain death with technetium 99m hexamethylpropylene amine oxime.
Costa DC; Motteux IM; McCready AC
Eur J Nucl Med; 1991; 18(7):503-6. PubMed ID: 1915475
[TBL] [Abstract][Full Text] [Related]
17. Quantitative single-photon emission tomography for tumour blood flow measurement in bronchial carcinoma.
Rowell NP; Flower MA; Cronin B; McCready VR
Eur J Nucl Med; 1993 Jul; 20(7):591-9. PubMed ID: 8370379
[TBL] [Abstract][Full Text] [Related]
18. A comparative technetium 99m hexamethylpropylene amine oxime SPET study in different types of dementia.
Habert MO; Spampinato U; Mas JL; Piketty ML; Bourdel MC; de Recondo J; Rondot P; Askienazy S
Eur J Nucl Med; 1991; 18(1):3-11. PubMed ID: 2019279
[TBL] [Abstract][Full Text] [Related]
19. In vivo metabolism and kinetics of 99mTc-HMPAO.
Lucignani G; Rossetti C; Ferrario P; Zecca L; Gilardi MC; Zito F; Perani D; Lenzi GL; Fazio F
Eur J Nucl Med; 1990; 16(4-6):249-55. PubMed ID: 2351174
[TBL] [Abstract][Full Text] [Related]
20. The use of technetium-99m hexamethylpropylene amine oxime labelled granulocytes with single-photon emission tomography imaging in the detection and follow-up of recurrence of infective endocarditis complicating transvenous endocardial pacemaker.
Ramackers JM; Kotzki PO; Couret I; Messner-Pellenc P; Davy JM; Rossi M
Eur J Nucl Med; 1995 Nov; 22(11):1351-4. PubMed ID: 8575490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]